Obermatt
See Similar Stocks →

Flags

Earnings warning

BioLife Slutn

NAQ:BLFS · US09062W2044
Life Sciences Tools & ServicesSmall

360

50
EV / EBIT1
Price / Owner Earnings98
Owner Earnings Yield1
Dividend Yield1
Price/Sales15
EV / Gross Profit13
Price/Book44
Return on Capital46
Cash Return on Capital55
Return on Equity54
EBIT Margin45
Gross Profitability48
Accruals13
Owner Earnings Margin48
Sales growth86
Profit growth49
Reinvestment4
Price momentum61
Debt load95
Refinancing33
Debt Payback1
Liquidity6
Analyst ratings89
Opinion Changes50
Price Target Upside54
Market mood42
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

BioLife Slutn clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded1987
Employees133
Websitebiolifesolutions.com
ISINUS09062W2044
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
GeneticsBiomedical EngineeringStem Cell TherapyBiotechnologyCommercialIndustrialMedical

Description

BioLife Solutions, Inc. operates as a life sciences company that develops, manufactures, and markets bioproduction tools and services, which are designed to improve quality and de-risk biologic manufacturing, storage, distribution, and transportation…

Analysis

Hope premium

BioLife Solutions, Inc. is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium.

Valuation data is not available for this company.

Growth is solid; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
74
2023202420252026

All-time high

81

Jan 2024

All-time low

57

Jan 2023

Average rank

71

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
15
11
38
62
Price/Earnings
3
58
58
6
Price/Book
44
40
58
79
Dividend Yield
1
1
1
1
Value (overall)
3
20
44
63

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare BioLife Slutn with its peers
Azenta
NSQ:AZTA
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Waters
NYQ:WAT
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
MaxCyte
NSQ:MXCT
17
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Tempus AI
NSQ:TEM
28
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Maravai LifeSciences Holdings
NSQ:MRVI
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →